Tourniquet-Test in HHT

University Hospital Essen

Status: Active, not recruiting

Conditions: HHT

Treatments: Diagnostic Test: Tourniquet Test

Study type: Interventional

Funder types: Other

Identifiers

NCT06266624

Tourniquet in HHT

Details and patient eligibility

About

The Tourniquet test is used as a diagnostic procedure for thrombocytopathies and vascular diseases. Currently, there is no evidence whether this test is also positive in hereditary haemorrhagic telangiectasia (HHT), a vasculopathy. The aim of this study was to investigate whether this non-invasive test could also be used as an additional diagnostic criterion in patients with HHT.

Full description

The Tourniquet test is used as a diagnostic procedure for thrombocytopathies and vascular diseases. Currently, there is no evidence whether this test is also positive in hereditary haemorrhagic telangiectasia (HHT), a vasculopathy. The aim of this study was to investigate whether this non-invasive test could also be used as an additional diagnostic criterion in patients with HHT.

Enrollment: 92 patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• In patients with confirmed HHT diagnosis (≥ 3 Curaçao criteria or positive molecular genetics)
• aged over 18 years

Exclusion criteria

• if inclusion criteria does not apply

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

92 participants in 1 patient group

Tourniquet Test

Experimental group

Description:

Patients with HHT patients who undergo the Tourniquet Test

Treatment:

Diagnostic Test: Tourniquet Test